New study establishes Curcugen® as a powerful post-exercise anti-inflammatory

摘要

DOLCAS BIOTECH LLC'S novel Curcugen® curcumin formulation is being primed for the sports health sector. Newly armed with self-affirmed CRAS designation as a safe, functional food ingredient, Curcugen is poised to feature in a comprehensive portfolio of sports supplements and post-workout bars, shakes, and beverages. A new clinical study endorses Curcugen's role as a compelling post-workout anti-inflammatory agent.Results of clinical research published in the Proceedings of the Seventeenth International Society of Sports Nutrition (ISSN) Conference and Expo, December 2020, confirmed Curcugen's positive anti-inflammatory, anti-oxidant and analgesic capacity on subjects engaging in acute exercise. In this double-blinded, placebo-controlled study, led by Neil Schwarz, PhD, 24 participants were randomized to either a daily dose of 500 mg of Curcugen or the equivalent dose in rice flour prior to an intense exercise protocol of 50 hurdles and 50 drop jumps. Joint range-of-motion (ROM), soreness, and markers of inflammation and oxidative stress where significantly better in the Curcugen group 72 hours post- exercise demonstrating its capabilities in accelerating post workout recovery.